Oxapex, New Alpha Innovation’s first product, has officially launched in New Zealand.

Agricultural Compounds and Veterinary Medicines (ACVM) in New Zealand approved Oxapex for a Variation Application submission on October 27, 2020. Changes made to the original submission have been accepted and approved.

Effective 31 July 2019, our company email address has been changed from "newaiinfo@newainnovation.com" to "newaiinfo@newalphainnovation.com".

Effective 3 June 2019, our company name has been changed from "New A Innovation Limited" to "New Alpha Innovation Limited".
Please note that the company structure, the current contracts and agreements as well as the Chinese company name “新意康醫藥科技有限公司” remain unchanged.

Oxapex®IDX has been added to the Index of Legally Marketed Unapproved New Animal Drugs for Minor Species at FDA.

New Alpha Innovation receives Minor Use Permit (permit to allow supply and minor use of an unregistered veterinary chemical product) from Australian Pesticides and Veterinary Medicines Authority (APVMA) for Oxapex®.

New Alpha Innovation receives approval of new drug registration from Agricultural Compounds and Veterinary Medicines (ACVM) in New Zealand for Oxapex®.